The pharmaceutical industry may usher in a golden decade of development, related production equipment concerned.

Since 2020, the pharmaceutical industry is undoubtedly the focus of investor
s and institutionsVaccines, innovative drugs and rapid testing technologies are the focus of attention in terms of segmentationIn the medium to long term, with the upgrading of the level of mass consumption, the enhancement of health care awareness, as well as the subsequent addition of more favorable policies, support and encourage investment in research and development, the pharmaceutical industry market development space is broadSome industry people believe that the future pharmaceutical industry will enter a new and faster growth stage of development, the domestic pharmaceutical industry may usher in the development of the golden decadeIn this context, related drugs and vaccine production equipment, medical equipment, etcwill also usher in opportunitiespharmaceutical production equipment (source: pharmaceutical network)several areas are favored
on the vaccine industry, with the national level of more attention to the field of disease prevention, the public awareness of vaccination, coupled with the recent new heavy-duty vaccine products continue to market, the vaccine industry will be rapid development, the market prospects are considerableData show that China's annual production of more than 1 billion copies of vaccines, and a wide range of vaccines, including for the prevention of hepatitis B, poliomyelitis, measles, pertussis, diphtheria, tetanus, the common pediatric disease strain reached 500 million copies, has been fully immunizedIn recent years, the state's support for the innovative pharmaceutical industry from research and development, review, production to listing has been accelerating, and innovative drugs have ushered in a golden development periodAccording to the Analysis report on China's pharmaceutical industry market outlook and investment strategic planning, china's innovative drug sales are expected to exceed 700 billion yuan by 2029, according to the Forward-Looking Industry Research Instituteat the same time, as a "water seller" CXO industry also ushered in a huge development opportunityIndustry analysts believe that with the global industrial transfer, overseas orders inflow, domestic-scale pharmaceutical companies to accelerate innovation transformation, as well as the rise of China's Biotech, domestic CXO demand short-term growth rate, is expected to increase in 2020 growth rate, the next 2-3 years of overall growth rate of domestic demand showed an upward trend Related production equipment concerned
as an industry chain, pharmaceutical and vaccine-related production equipment, medical equipment market will also usher in opportunities and challenges Among them, in the current context, vaccine-related production equipment manufacturers in particular have attracted the attention of many investors For example, Dongfulong recently said on an interactive platform, the company's main biological engineering products and services include bioreactors, bio-wastewater inactivation, separation purification (ultrafiltration, tomography, etc.) and other fields, currently for mono-resistance, recombinant protein, blood products and human/animal vaccines, etc to provide services, not only to provide customers with process equipment, but also to provide customers with integrated solutions (process and equipment, engineering), bioprocess integration and other services At the same time, it said that the company's overall production capacity is sufficient ChengYitong recently in response to investor questions on the interactive platform, said that the company's business mainly includes the field of pharmaceutical bio-intelligence manufacturing and rehabilitation of medical devices two pieces, the current product is not involved in the production of vaccine-related equipment, but the company's 2019 research and development of material management traceability system, can achieve the whole process from material storitor into the workshop to the product out of the workshop management and traceability, pharmaceutical enterprises, including vaccine production enterprises will have a positive role in the future development of the market will also be an important direction In addition, the increase in the company's advance receipts in the first quarter was mainly due to the increase in orders in addition, in early June, Chutian Technology also responded to investors on the interactive platform, said that the company is committed to providing pharmaceutical companies with the overall solution of intelligent medicine, according to customer requirements to produce customized products.